Tag: Disaster Planning

CDC: Characteristics of patients who died with COVID-19, February 12-May 18

Editor's Note This July 10 report from the Centers for Disease Control & Prevention (CDC) provides detailed demographic and clinical information on a subset of 10,647 people who died with COVID-19 (ie, decedents) in 16 US public health jurisdictions between February 12 and May 18. The researchers found that: 60.6%…

Read More

By: Judy Mathias
July 13, 2020
Share

Role of lifestyle, social connections in contracting COVID-19

Editor's Note Current research shows that unhealthy lifestyle choices, including smoking and lack of exercise, along with emotional stressors like social isolation and interpersonal conflicts are important risk factors for developing upper respiratory infections, and it is possible these same factors increase the risk of contracting COVID-19, researchers from Carnegie…

Read More

By: Judy Mathias
July 9, 2020
Share

Cleveland Clinic researchers see rise in stress cardiomyopathy during COVID-19 pandemic

Editor's Note Cleveland Clinic researchers have found a significant increase in patients with stress cardiomyopathy during the COVID-19 pandemic. For the study, cardiologists examined 1,914 patients coming to the Cleveland Clinic with heart symptoms between March 1 and April 30 and compared them with patients in four time periods before…

Read More

By: Judy Mathias
July 9, 2020
Share

Joint Commission places hold on public reporting of perinatal care measures

Editor's Note The Joint Commission on July 8 announced that because of extended data submission timelines and optional reporting for fourth quarter 2019 data due to COVID-19, the planned July 2020 display of two ORYX Perinatal Care measures on Quality Check has been placed on hold. The measures are: PC-02…

Read More

By: Judy Mathias
July 9, 2020
Share

Potential effect of contaminated bronchoscopes on COVID-19 patients

Editor's Note In this Letter to the Editor, epidemiologist and researcher Cori L. Ofstead, MSPH, and colleagues caution that because of high bronchoscope contamination rates found during routine use in previous studies, the possibility of bronchoscopy-associated transmission of COVID-19 or other pathogens must be considered. Though high-level disinfection should eliminate…

Read More

By: Judy Mathias
July 8, 2020
Share

New COVID-19 test uses blood, saliva, urine samples

Editor's Note A new COVID-19 test that uses blood, saliva, and urine samples and can deliver results within 30 to 45 minutes without expensive lab equipment has been developed by researchers at Beaumont Research Institute, Royal Oak, Michigan. The test can be used at the point of risk, such as…

Read More

By: Judy Mathias
July 8, 2020
Share

Investigation of COVID-19 nosocomial infections identifies close contact, not airborne transmission as cause

Editor's Note This investigation, by researchers at the University of California-Davis Medical Center, of the pattern of transmission of COVID-19 during two nosocomial outbreaks finds that close contact between patients and healthcare workers (HCWs) not airborne transmission was the cause of the outbreak. Two separate patients were admitted in February…

Read More

By: Judy Mathias
July 7, 2020
Share

National COVID-19 survey finds significant mental health effects

Editor's Note In a nationwide survey that assessed the effects of the COVID-19 pandemic on the emotional wellbeing of adults, 90% of respondents reported experiencing emotional distress. The survey of 1,500 adults found that: 80% were frustrated with not being able to do what they normally enjoy doing 80% were…

Read More

By: Judy Mathias
July 7, 2020
Share

Study: Hydroxychloroquine lowers COVID-19 death rate

Editor's Note In this study, researchers from Henry Ford Health System in Michigan found that hydroxychloroquine alone decreased the mortality hazard ratio of COVID-19 by 66%, and hydroxychloroquine with azithromycin decreased the ratio by 71%, compared to neither treatment. The vast majority of the 2,541 COVID-19 patients included in the…

Read More

By: Judy Mathias
July 6, 2020
Share

Late-stage COVID-19 vaccine trials to start this summer

Editor's Note The National Institute of Allergy and Infectious Diseases director Anthony Fauci says COVID-19 vaccine candidates will start moving into late-stage clinical trials by the end of July, continuing through the summer and into fall, the July 2 Reuters reports. The director of the National Institutes of Health, Dr…

Read More

By: Judy Mathias
July 6, 2020
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat